| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |